KEGG    Network variation - Bladder cancer
[ Network menu | Network entry | Help ]
ENTRYnt06265
NameBladder cancer
CategoryDisease view; Cancer
Pathwayhsa05219 Bladder cancer
DiseaseH00022 Bladder cancer
Display drug-target relation   disease type
ERK signaling
N00001    EGFEGFRGRB2SOSRASRAFMEKERKCCND1
N00006      EGFR*GRB2SOSRASRAFMEKERK
N00041      EGFR*GRB2SOSRASRAFMEKERK
N00021    EGF(ERBB2+EGFR)GRB2SOSRASRAFMEKERK
N00022    EGF(ERBB2*+EGFR)GRB2SOSRASRAFMEKERK
N00019    FGFFGFRGRB2SOSRASRAFMEKERK
   D1
 |
                
N00011      FGFR3*GRB2SOSRASRAFMEKERKMSK1MYC
N00077            HRAS*RAFMEKERKMSK1MYC
N00078            HRAS*RAFMEKERKMSK1MYC
 
Cell cycle
N00066    CDKN2AMDM2TP53CDKN1A(CCND+CDK4/6)RB1E2F
N00067    CDKN2A*MDM2TP53CDKN1A(CCND+CDK4/6)RB1E2F
N00069          CDKN2A(CCND+CDK4/6)RB1E2F
N00071          CDKN2A*(CCND+CDK4/6)RB1E2F
N00074              RB1*E2F
N00075              RB1*E2F
 
Transcription
N00115    TP53*(CDKN1A,GADD45,BAX..


Drug name
D1D10927Erdafitinib (JAN/USAN/INN)